Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedExpanded and updated the Locations section with entries across multiple regions (US states, Alberta, Ontario, Gyeong Gi-do) and added Revision: v3.3.3. Older location blocks were removed.SummaryDifference1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedPubMed-based publication notes were updated to state that publications are automatically filled from PubMed and to include a new revision label (v3.3.2). The earlier PubMed note and revision label (v3.2.0) were removed.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the government funding status notice; the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check69 days agoChange DetectedNo significant changes observed between the old and new VOYAGER study pages for NCT03465722.SummaryDifference0.2%

- Check91 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check98 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.